These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29287594)

  • 1. Comprehensive molecular biomarker identification in breast cancer brain metastases.
    Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
    J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
    An M; Zang X; Wang J; Kang J; Tan X; Fu B
    Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
    Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
    Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.
    Lee JY; Park K; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Hong M; Do IG; Ahn T; Lee SK; Bae SY; Kim SW; Lee JE; Nam SJ; Kim DH; Jung HH; Kim JY; Ahn JS; Im YH; Park YH
    Oncotarget; 2015 Dec; 6(41):43731-42. PubMed ID: 26527317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential genes related to breast cancer brain metastasis in breast cancer patients.
    Zhang L; Wang L; Yang H; Li C; Fang C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34541602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival.
    Giannoudis A; Clarke K; Zakaria R; Varešlija D; Farahani M; Rainbow L; Platt-Higgins A; Ruthven S; Brougham KA; Rudland PS; Jenkinson MD; Young LS; Falciani F; Palmieri C
    Sci Rep; 2019 Dec; 9(1):18518. PubMed ID: 31811234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.
    Wikman H; Sielaff-Frimpong B; Kropidlowski J; Witzel I; Milde-Langosch K; Sauter G; Westphal M; Lamszus K; Pantel K
    PLoS One; 2012; 7(10):e47537. PubMed ID: 23118876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Expression Profiling of Breast Cancer Brain Metastasis.
    Lee JY; Park K; Lee E; Ahn T; Jung HH; Lim SH; Hong M; Do IG; Cho EY; Kim DH; Kim JY; Ahn JS; Im YH; Park YH
    Sci Rep; 2016 Jun; 6():28623. PubMed ID: 27340107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition.
    Duan S; Luo X; Zeng H; Zhan X; Yuan C
    Breast Cancer; 2020 Nov; 27(6):1072-1081. PubMed ID: 32458152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of breast cancer CTCs associated with brain metastasis.
    Boral D; Vishnoi M; Liu HN; Yin W; Sprouse ML; Scamardo A; Hong DS; Tan TZ; Thiery JP; Chang JC; Marchetti D
    Nat Commun; 2017 Aug; 8(1):196. PubMed ID: 28775303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and Extracellular Vesicles as Distinctive Biomarkers of Precocious and Advanced Stages of Breast Cancer Brain Metastases Development.
    Figueira I; Godinho-Pereira J; Galego S; Maia J; Haskó J; Molnár K; Malhó R; Costa-Silva B; Wilhelm I; Krizbai IA; Brito MA
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.
    Shen Q; Sahin AA; Hess KR; Suki D; Aldape KD; Sawaya R; Ibrahim NK
    Oncologist; 2015 May; 20(5):466-73. PubMed ID: 25802405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonality of circulating tumor cells in breast cancer brain metastasis patients.
    Riebensahm C; Joosse SA; Mohme M; Hanssen A; Matschke J; Goy Y; Witzel I; Lamszus K; Kropidlowski J; Petersen C; Kolb-Kokocinski A; Sauer S; Borgmann K; Glatzel M; Müller V; Westphal M; Riethdorf S; Pantel K; Wikman H
    Breast Cancer Res; 2019 Sep; 21(1):101. PubMed ID: 31481116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity.
    McMullin RP; Wittner BS; Yang C; Denton-Schneider BR; Hicks D; Singavarapu R; Moulis S; Lee J; Akbari MR; Narod SA; Aldape KD; Steeg PS; Ramaswamy S; Sgroi DC
    Breast Cancer Res; 2014 Mar; 16(2):R25. PubMed ID: 24625110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors.
    Thulin A; Andersson C; Werner Rönnerman E; De Lara S; Chamalidou C; Schoenfeld A; Kovács A; Fagman H; Enlund F; Linderholm BK
    Sci Rep; 2021 Dec; 11(1):23548. PubMed ID: 34876602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
    Huang RSP; Haberberger J; McGregor K; Mata DA; Decker B; Hiemenz MC; Lechpammer M; Danziger N; Schiavone K; Creeden J; Graf RP; Strowd R; Lesser GJ; Razis ED; Bartsch R; Giannoudis A; Bhogal T; Lin NU; Pusztai L; Ross JS; Palmieri C; Ramkissoon SH
    Oncologist; 2021 Oct; 26(10):835-844. PubMed ID: 34105210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.
    Kanchan RK; Siddiqui JA; Mahapatra S; Batra SK; Nasser MW
    Mol Cancer; 2020 Feb; 19(1):29. PubMed ID: 32059676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
    Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
    Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in the expression of receptors in the human breast cancer metastasized to the brain.
    Rao PS; Labhart M; Mayhew SL; Thirumala S; Rao US
    Tumour Biol; 2014 Jul; 35(7):7267-73. PubMed ID: 24777335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.